arsenic has been researched along with Granuloma, Hodgkin in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (75.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (6.25) | 29.6817 |
2010's | 3 (18.75) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hao, L; Wang, H; Wang, X; Xu, G; Zhao, J | 1 |
Bhalla, S; Crombie, J; Evens, AM; Gartenhaus, RB; Kandela, I; Mazar, A; Ravi, D; Sharma, J | 1 |
Boccia, RV; Craig, MD; Hamilton, BL; Hosein, PJ; Lewis, JJ; Lossos, IS; Tallman, MS | 1 |
Bommert, K; Dorken, B; Hinz, M; Janz, M; Jundt, F; Lietz, A; Mathas, S; Scheidereit, C | 1 |
DEJMAL, V; MUSIL, J | 2 |
KNOCK, FE | 1 |
Danieli, G | 1 |
MARCHAL, G | 1 |
BOLTANSKI, E; DESGREZ, H; GUERIN, RA; RYMER, M | 1 |
ABBATUCCI, J; PIERQUIN, B; TUBIANA, M | 1 |
INNES, J | 1 |
MALLET, L | 1 |
DUHAMEL, G; MALLET, L; MARCHAL, G | 1 |
Grünwald, HW; Rosner, F | 1 |
Gertler, W | 1 |
1 review(s) available for arsenic and Granuloma, Hodgkin
Article | Year |
---|---|
Cytotoxic drugs and leukaemogenesis.
Topics: Adult; Aged; Arsenic; Benzene; Bone Marrow; Breast Neoplasms; Female; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Mycosis Fungoides; Ovarian Neoplasms; Paraproteinemias; Waldenstrom Macroglobulinemia | 1980 |
1 trial(s) available for arsenic and Granuloma, Hodgkin
Article | Year |
---|---|
A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Arsenicals; Female; Glutathione; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Recurrence; Treatment Outcome | 2012 |
14 other study(ies) available for arsenic and Granuloma, Hodgkin
Article | Year |
---|---|
Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; Hodgkin Disease; Humans; Leukemia, Promyelocytic, Acute; Liver; Male; Oxides | 2013 |
The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Topics: Animals; Apoptosis; Arsenic; Arsenicals; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Glutathione; Hodgkin Disease; Humans; Intracellular Space; Lymphoma, T-Cell; Mice; Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis.
Topics: Animals; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Down-Regulation; Gene Expression Profiling; Hodgkin Disease; Humans; I-kappa B Kinase; Mice; Mice, SCID; NF-kappa B; Oxides; Protein Serine-Threonine Kinases; Reed-Sternberg Cells; Sodium Compounds; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
[Biochemical findings in experimental & clinical application of radioarsenic (As 76)].
Topics: Arsenicals; Hodgkin Disease; Humans | 1957 |
[Attempt at treating pruritus in malignant lymphogranuloma by administration of As 76].
Topics: Arsenicals; Hodgkin Disease; Humans; Pruritus | 1957 |
ENZYME STUDIES ON SULFHYDRYL INHIBITORS FOR CANCER THERAPY.
Topics: Animals; Antineoplastic Agents; Arsenicals; Chondrosarcoma; Clinical Enzyme Tests; Dogs; Hodgkin Disease; Research; Sulfhydryl Compounds; Sulfhydryl Reagents | 1963 |
[Therapy of hemoblastosis. I. Elements of cytostatic and symptomatic therapy].
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Arsenicals; Colchicine; Hodgkin Disease; Humans; Hydrazines; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Multiple Myeloma | 1966 |
[Radioactive phosphorus and radioactive arsenic in the treatment of malignant blood diseases].
Topics: Arsenic; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Phosphorus; Polycythemia Vera; Radioisotopes | 1952 |
[An atypical aspect of Hodgkin's disease treatment with radiotherapy, radioactive phosphorus and arsenic].
Topics: Arsenic; Fistula; Hodgkin Disease; Humans; Phosphorus; Phosphorus Radioisotopes; Phosphorus, Dietary; Radioactivity; Radioisotopes; Radiotherapy | 1954 |
[Arsenic 76 fixation in the skin in various malignant types of erythroderma].
Topics: Arsenic; Dermatitis, Exfoliative; Hodgkin Disease; Humans; Mycosis Fungoides; Radioisotopes; Skin | 1954 |
The treatment of Hodgkin's disease.
Topics: Arsenic; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radioisotopes | 1951 |
[Use of arsenic 76, the radioactive isotope, in the treatment of certain malignant skin diseases].
Topics: Arsenic; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Radioactivity; Radioisotopes; Skin Diseases | 1951 |
[Radioactive arsenic in treatment of Hodgkin's disease and mycosis fungoides].
Topics: Arsenic; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mycosis Fungoides; Radioisotopes | 1952 |
[Nosology and clinical course of cutaneous reticuloses].
Topics: Anti-Inflammatory Agents; Arsenic; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphatic Diseases; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Mast-Cell Sarcoma; Mycosis Fungoides; Plasmacytoma; Skin Neoplasms; Urticaria Pigmentosa | 1969 |